---
layout: post
title: "Certain Products Containing Pyraclostrobin and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based Upon a Consent Order Stipulation; Issuance of Consent Orders; Termination of Investigation"
date: 2026-02-05 18:58:52 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-08211
original_published: 2022-04-18 00:00:00 +0000
significance: 8.00
---

# Certain Products Containing Pyraclostrobin and Components Thereof; Notice of a Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety Based Upon a Consent Order Stipulation; Issuance of Consent Orders; Termination of Investigation

**Published:** February 05, 2026 18:58 UTC
**Source:** Federal Register
**Original Published:** April 18, 2022 00:00 UTC
**Document Number:** 2022-08211

## Summary

Notice is hereby given that the U.S. International Trade Commission has determined not to review initial determinations ("ID") (Order No. 5) of the presiding chief administrative law judge ("ALJ") terminating the investigation in its entirety based upon a consent order stipulation. The Commission has entered consent orders against the respondents.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/04/18/2022-08211/certain-products-containing-pyraclostrobin-and-components-thereof-notice-of-a-commission)
- API: https://www.federalregister.gov/api/v1/documents/2022-08211

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
